Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders

L Marandino, Joep de Jong, D Raggi, A Gallina, M Bandini, P Giannatempo, M Colecchia, A Briganti, F Montorsi, E Davicioni, R Seiler, P Black, EA Gibb, A Necchi

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)S21
JournalEuropean Journal of Cancer
Volume138
DOIs
Publication statusPublished - 2020

Cite this